Experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head

Author:

Pkheshkhova B. G.1ORCID,Mudunov A. M.2ORCID,Pak M. B.2ORCID,Zeynalova P. A.2ORCID,Batsev A. F.3ORCID

Affiliation:

1. Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; Рeoples’ Friendship University of Russia (RUDN University)

2. Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

3. Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Abstract

This article presents the experience of successful use of immunotherapy in treatment of locally advanced inoperable squamous cell carcinoma of the hairy part of the head.

Publisher

Publishing House ABV Press

Reference18 articles.

1. Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 252 с. Malignant neoplasms in Russia in 2021 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022. 252 p. (In Russ.).

2. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012;166(5):1069–80. DOI: 10.1111/j.1365-2133.2012.10830.x

3. Brougham N.D., Dennett E.R., Cameron R., Tan S.T. The incidence of metastasis form cutaneous squamous cell carcinoma and the impact of its risk factors. J Surg Oncol 2012;106(7):811–5. DOI: 10.1002/jso.23155

4. Benjamin C.L., Ananthaswamy H.N. p53 and the pathogenesis of skin cancer. Toxicol Appl Pharmacol 2007;224(3):241–8. DOI: 10.1016/j.taap.2006.12.006

5. Liu Q., Yu S., Zhao W. et al. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer 2018;17(1):53. DOI: 10.1186/s12943-018-0793-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3